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Abstract  
Megakaryocytes in the bone marrow are immersed in a network of 
extracellular matrix components that regulates platelet release into the 
circulation. Combining biological and bioengineering approaches, we found 
that the activation of transient receptor potential cation channel subfamily V 
member 4, a mechano-sensitive ion channel, is induced upon megakaryocyte 
adhesion on softer matrices. This response promoted platelet production by 
triggering a cascade of events that lead to calcium influx, β1 integrin activation 
and internalization, and Akt phosphorylation, responses not found on stiffer 
matrices. Lysyl oxidase is a physiological modulator of bone marrow matrix 
stiffness via collagen cross-linking. In vivo inhibition of lysyl oxidase and 
consequent matrix softening lead to transient receptor potential cation 
channel subfamily V member 4 activation cascade and increased platelet 
levels. Concurrently, in vitro proplatelet formation was reduced on a 
recombinant enzyme-mediated stiffer collagen. These results suggest a novel 
mechanism by which megakaryocytes, through transient receptor potential 
cation channel subfamily V member 4, sense extracellular matrix 
environmental rigidity and release platelets accordingly.  
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Introduction 
Megakaryocytes (Mks) reside within the bone marrow (BM), where they 
mature to extend proplatelets, at the end of which newly formed platelets are 
assembled and released into the bloodstream 1-4. Different extracellular matrix 
components (ECM), in the BM, actively regulate megakaryopoiesis5-7. In 
earlier studies, it was demonstrated that type IV collagen sustains proplatelet 
formation (PPF), opposite to type I collagen, which is a fundamental negative 
regulator of PPF through integrin α2β1/Rho/ROCK axis engagement 8-12. In 
addition, recent studies highlighted the direct involvement of PI3K/Akt and 
MAPK/ERK pathways in PPF 13-17. Interestingly, ECM component stiffness 
was shown to be inversely correlated to Mk maturation and PPF8,10,18. 
Cell contact with ECM components occurs through integrins which transduce 
the signals from the ECM to the cell cytoskeleton19-21. However, to sense the 
extracellular environment, integrins act in concert with different mechano-
sensitive ion channels 22,23. Among these, the transient receptor potential 
cation channel subfamily V member 4 (TRPV4) is a membrane mechano-
sensitive ion channel whose activation has been linked to activation of β1 
integrin a major collagen-binding integrin receptor subunit 24-26. Interestingly, 
TRPV4 activity has been demonstrated to modulate PI3K/Akt and MAPK/ERK 
pathways in endothelial cells upon physical stimuli applied to the cell 
membrane 24. In the current study, we demonstrate a new mechanism by 
which Mks sense the environmental mechanics to regulate their maturation 
and platelet production. On soft collagenous substrates, TRPV4 expressed on 
the Mk surface was activated, inducing calcium influx, β1 integrin activation 
and internalization, with consequent Akt phosphorylation and proplatelet 
formation.     
 
Methods 
In vitro megakaryocyte cultures 
Human CD34+ cells were isolated, separated and cultured, as described 
previously 27,28. All human samples were collected in accordance with the 
ethical committee of the IRCCS Policlinico San Matteo Foundation and the 
principles of the Declaration of Helsinki. For collagen receptor inhibition, Mks 
at day 13 of culture were incubated with 10 μg/mL anti-β1 integrin blocking 
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antibody (Millipore, clone P5D2), 10 μg/mL anti-GPVI blocking antibody (a 
kind gift of Prof. Jandrot Perrus) or with 200 nM (125 ng/mL) Discoidin 
Domain Receptor 1 (DDR1) -IN-1 (Tocris), a selective DDR1 tyrosine kinase 
inhibitor, for one hour prior to be plated on type I or type IV collagen for 3 
hours. For Akt inhibition experiments, Mks at day 13 of culture were treated 
with 10 μM Akt1/2 inhibitor (Sigma Aldrich) for 30 minutes and then plated on 
collagens for 16 hours for PPT evaluation. For treatment with the TRPV4 
inhibitors (RN-1734, HC067047, Sigma Aldrich) Mks at day 13 of culture were 
incubated with vehicle or 10 μM of the indicated TRPV4 inhibitor for 30 
minutes prior to be plated on collagens for 3 or 16 hours. For treatment with 
the TRPV4 agonist (GSK1016790A, Sigma Aldrich), Mks at day 13 of culture 
were incubated or not with 10 nM GSK1016790A for 10 minutes prior to be 
plated on collagens for 3 hours.  
 
Evaluation of megakaryocyte spreading and proplatelet formation 
Evaluation of Mk spreading and proplatelet formation (PPF) onto collagens 
was performed as previously described 29. Please refer to Supplemental 
Methods for technical details. 
 
Immunoprecipitation and Western blotting 
For immunoprecipitation and western blotting analysis, cultured Mks and 
primary BM immunomagnetically-sorted Mks (CD41+; Biolegend) were 
collected, washed twice at 4°C and lysed as previously described 30. For 
active β1 integrin staining, samples were not reduced. Please refer to 
Supplemental Methods for technical details. 
 
Immunofluorescence microscopy 
For cell immunofluorescence staining, 1x105 Mks at day 13 of culture were 
harvested and plated on collagen coated coverslips. Adhering cells were 
washed, fixed, permeabilzed and stained as previously described29. Please 
refer to Supplemental Methods for technical details. 
 
Internalization assays 
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For immunofluorescence internalization assay, Mks were treated as living 
cells with 15 μg/mL of the anti-β1 integrin mAb (Abcam) and acid washed 
before fixation as previously described 31,32. Mks were then fixed, 
permeabilized, and stained with the appropriate secondary antibody. Western 
blot internalization was evaluated as previously described 33. Please refer to 
Supplemental Methods for technical details.  
 
Silk film fabrication 
Silk films were produced as previously described 34. Type I or type IV collagen 
(25 µg/mL) were coated to the film surface overnight at 4°C. Please refer to 
Supplemental Methods for technical details. 
 
Elastic modulus determination via Atomic Force Microscope (AFM) 
Elastic modulus maps were taken on an Asylum Research MFP-3D AFM 
(Asylum Research) using AC240TS-R3 cantilevers (Asylum Research) with a 
nominal spring constant of 2 N/m. Please refer to Supplemental Methods for 
technical details. 
 
[Ca2+]i measurements 
Mks at day 13 of culture were harvested and plated onto substrate-coated 
cover-slips in 24-wells plates (1x105 cells/well). After 60 minutes at 37°C and 
5% CO2, Mks were loaded with 4 µM fura-2 AM in Physiological salt solution 
(PSS) for additional 30 minutes and analyzed as previously described17. 
Please refer to Supplemental Methods for technical details. 
 
Animals and in vivo treatment 
C57/BL6 wild type mice were from Charles River Laboratories. Mice were 
housed at the animal facility of the Department of Physiology, section of 
General Physiology, University of Pavia (approval # 1302/2015). All mice 
were sacrificed according to the current European legal Animal Practice 
requirements. In vivo Lysyl Oxidase (LOX) inhibition by BAPN treatment was 
carried out using a protocol modified from previous studies35. Please refer to 
Supplemental Methods for technical details. 
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In vivo bone marrow stiffness  
The mechanical properties of femoral BM from mouse treated with BAPN and 
controls were measured with a Zwick/Roell Z005 testing device (Zwick GmbH 
& Co) equipped with a 10 N load cell as previously described36. Please refer 
to Supplemental Methods for technical details.  
 
Flow cytometry  
For the analysis of pAkt in BM Mks, femurs were flushed, red blood cells lysed 
with a 0.8% ammonium chloride solution, the remaining cells were washed by 
centrifugation with PBS and stained with anti-pAkt antibody (20 μL per test; 
BD Pharmingen) and anti-CD41 antibody (0.1 mg/mL; Biolegend) following 
the manufacturer instructions. All Mk samples, from the different tested 
sources, were routinely characterized as CD41+CD42b+ and CD3-CD4-CD8-
CD11b-CD19-CD33- cells, using appropriate antibodies (Beckman Coulter 
Inc.). Please refer to Supplemental Methods for technical details. 
 
Bone marrow explant analysis 
Bone marrow explants were isolated and analyzed based on a previous 
protocol 37. Please refer to Supplemental Methods for technical details.  
 
Statistics 
Values are expressed as mean ± Standard Deviation (SD). t test was used to 
analyze experiments. A value of p<0.05 was considered statistically 
significant. All experiments were independently repeated at least three times. 
 
For RT-PCR and quantitative real time PCR, tissue collection and 
immunohistochemistry, reticulated platelet analysis and LOX-mediated 
collagen crosslinking please refer to Supplemental Methods. 
 
Results 
Type I and type IV collagen differently impact megakaryocyte adhesion  
To evaluate the impact of collagen stiffness on Mk behavior, coverslips were 
coated with type I or type IV collagens and Young's modulus was evaluated 
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by AFM-based nano-indentation10,29. As we previously demonstrated, type I 
collagen fibrils presented an elasticity >150 megapascal units (MPa), whereas 
material in early stage of self-aggregation had values in the order of 5-75 
MPa10. On the contrary, more homogeneous values in the order of <10 MPa 
were found during the analysis of type IV collagen Young moduli. 
Consistently, nano-indentation studies on live cells plated on the two different 
collagens after 3 hours of adhesion revealed values ranging from 290 to 3,600 
Pa (weighted average 1,036 Pa) in Mks plated on type I collagen, while 
values ranging from 300 to 1,400 Pa (weighted average 667 Pa) were 
obtained with Mks plated on type IV collagen (Figure 1A). As a result of the 
different stiffness, Mks remained spread over a 16 hours incubation on type I 
collagen, while they rearranged their cytoskeleton and extended proplatelets 
on type IV collagen (Figure 1 B-C).  
 
Megakaryocyte β1 integrin activation and internalization vary depending 
on the type of collagen  
We hypothesized that specific collagen receptors may be responsible of the 
observed Mk behavior on type I and type IV collagens. qRT-PCR analysis 
revealed that the most expressed collagen-interacting integrin domains were 
β1>α2, with DDR1 and GPVI expressed at a similar level as α2 (Figure 2A). 
As shown in Figure 2A, the most important reduction in Mk adhesion was 
obtained inhibiting β1 integrin, while DDR1 and GPVI inhibition did not 
significantly affect Mk adhesion relative to untreated controls10,30. β1 integrin 
activation was studied in Mks plated on type I and type IV collagens at the 3 
time points used for functional studies (3, 8 and 16 hours), by employing a 
monoclonal antibody directed against epitopes in the 355–425 region (hybrid 
domain), whose expression reflects the activity of β1 integrin 38. An increase 
of β1 integrin activation was observed on type IV collagen, compared to type I 
collagen, after 3 and 8 hours of adhesion, reaching a similar value under both 
conditions after 16 hours (Figure 2B). Consistently, internalization assays 
showed that membrane distributed β1 integrin was reduced on Mks plated on 
type IV collagen as compared to type I collagen (Figure 2C).  
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Substrate stiffness modulates β1 integrin dynamics  
To prove that β1 integrin activation and internalization was determined by 
collagen substrate stiffness, silk fibroin films were fabricated with imposed 
elasticity and were afterwards coated with 25 μg/mL type I or type IV 
collagens34. Silk films with two different ranges of elasticity were chosen on 
the basis of previous results: a softer silk film (≤10 MPa) was chosen as the 
optimum condition to maximize Mk function, while a stiffer silk film (≥90 MPa) 
was chosen as a condition proven to decrease PPF34. Importantly, it is 
demonstrated that there are no specific cell-binding epitopes on the silk that 
would bias the outcomes39. As shown in Figure 3A, Mks extended 
proplatelets after 16 hours of adhesion on both collagens coated on soft films, 
while they maintained the spread form, independently on the collagen type, if 
plated on stiffer films. Lower stiffness promoted higher activation of the β1 
integrin in Mks plated on both collagen type-coated silk films, as 
demonstrated by western blot and immunofluorescence staining (Figure 3B, 
Supplemental Figure 1), with increased β1 integrin internalization (Figure 
3C).  
 
PI3K/Akt-dependent proplatelet formation on soft collagen substrate 
To understand the involvement of PI3K/Akt and MAPK/ERK signaling 
pathways in mediating the effect of soft collagen, Mks plated on type I and 
type IV collagen were lysed after 3, 8 and 16 hours. Western blot analysis 
demonstrated an important difference in Akt and ERK activation (Figure 4A). 
Specifically, ERK phosphorylation peaked after 3 hours on type I collagen, 
remaining higher up to 16 hours compared to type IV collagen, while Akt 
phosphorylation appeared constantly higher in Mks plated on type IV 
compared to type I collagen. Considering favorable PPF on type IV collagen, 
these results suggested a role for Akt phosphorylation as a positive mediator 
of PPF. Consistently, treatment of Mks plated on type IV collagen with a 
specific Akt inhibitor resulted in a significant reduction of PPF (Figure 4A). 
The role of substrate elasticity in Akt and ERK phosphorylation was further 
explored by using the silk fibroin film approach. Akt phosphorylation increased 
on soft collagen substrates, while ERK phosphorylation was unaffected 
(Figure 4B). Finally, inhibition of Akt in Mks plated on type I collagen-coated 
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soft films led to a reduction in PPF by about 80%, compared to untreated cells 
(Figure 4B). Accordingly, taking advantage of our system for platelet 
production through porous silk films 34, we showed that Akt inhibition 
significantly reduced the increase of platelet production obtained on soft 
collagen substrates (Supplemental Figure 2).  
 
Megakaryocytes express functional mechano-sensitive TRPV4 ion 
channel 
It has been demonstrated that, in endothelial cells, upon mechanical stress, 
β1 integrin activation determines the TRPV4 ion channel opening, which 
allows calcium influx inside the cell cytoplasm, supporting further β1 integrin 
engagement. Here, we show that human Mks expressed on their membrane 
functional TRPV4 ion channels (Figure 5A-5B) and that, upon adhesion onto 
type IV collagen, human Mks stained with FURA2-AM display calcium 
oscillations of significant higher frequency and amplitude than those observed 
during adhesion on type I collagen. Inhibition of TRPV4 channels with a 
selective antagonist (RN1734) led to a significant decrease in the amplitude of 
calcium spikes only on type IV collagen, but not on type I collagen, thus 
suggesting that calcium flux through TRPV4 differs in Mks plated on the two 
collagen types (Figure 5C). The increased activation of TRPV4 on type IV 
collagen and on soft collagen substrates was also confirmed by 
immunoprecipitation of phosphorylated TRPV4 followed by western blot 
analysis (Supplemental Figure 3) 40.  
 
β1 integrin activation, Akt phosphorylation and proplatelet formation on 
type IV collagen were sustained by TRPV4  
To test whether TRPV4 channels mediate β1 integrin activation and Akt 
phosphorylation, both proteins were analyzed upon Mk treatment with a 
specific TRPV4 inhibitor (RN-1734) on type IV collagen and with a specific 
TRPV4 agonist (GSK1016790A) on type I collagen. Blocking TRPV4 activity 
with RN-1734 on type IV collagen resulted in a significant decrease of β1 
integrin activation and Akt phosphorylation (Figure 6A). Consistently, the 
inhibition of TRPV4 activity resulted in diminished PPF on type IV collagen 
(Figure 6B), thus confirming the active role of the mechano-sensitive 
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TRPV4/β1integrin/Akt axis in PPF. On the contrary, forcing TRPV4 activation 
with GSK1016790A resulted in increased β1 integrin activation, Akt 
phosphorylation (Figure 6C) and β1 integrin internalization in Mks plated on 
type I collagen (Figure 6D).   
 
Lysyl oxidase-mediated collagen crosslinking inhibition increases PPF 
and platelet production in vivo 
A key regulator of collagen stiffness in vivo is the secreted enzyme lysyl 
oxidase (LOX), which by oxidative deamination of lysine residues on collagen, 
leads to cross-linked aldehydes, contributing to a tight and stiffer ECM 41. To 
support the impact of collagen substrate elasticity on platelet production in 
vivo, mice were treated with a specific LOX inhibitor, which has been 
demonstrated to reduce tissue stiffness 42,43. Inhibition of LOX, by beta-
aminopropionitrile (BAPN) treatment, an irreversible inhibitor of LOX, 
diminished the bone marrow elastic modulus (Figure 7A) and reduced 
collagen fiber dimension in cortical bone (Supplemental Figure 4). As shown 
in Figure 7B, the reduction of bone marrow stiffness led to an increase in 
peripheral platelet count, while the count of the other blood cells was 
unchanged (Supplemental Table 1). The percentage of newly released 
reticulated platelets was significantly increased in treated mice, confirming 
that the boost in platelet numbers was mainly due to newly formed platelets 
(Figure 7B). Of note, the number of bone marrow Mks was not significantly 
affected by BAPN treatment, thus demonstrating that the increase in 
peripheral blood platelet counts was not due to a higher Mk number 
(Supplemental Figure 5). Interestingly, Akt phosphorylation was augmented 
in BAPN-treated bone marrow Mks as compared to CTRL by means of 
immunofluorescence imaging of bone marrow sections and flow cytometry 
analysis of flushed bone marrow (Figure 7C). To study PPF within bone 
marrow in LOX-inhibited and control mice, fresh bone marrow explants were 
examined by videomicroscopy (Supplemental Figure 6). Through this 
approach, Mks, recognized by their morphology, became visible at the 
periphery of the explant as round cells or as cells extending thick protrusions 
or proplatelets. Importantly, TRPV4 activation was analyzed in Mks explanted 
from these scenarios by evaluating the extent of TRPV4 phosphorylation, 
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which enhances TRPV4-mediated calcium inflow and may be employed as 
surrogate to monitor TRPV4 activation when the direct measurement of 
calcium signals is not feasible 40. Diminishing the bone marrow stiffness 
resulted in an increase of TRPV4 activation in Mks as demonstrated by 
western blot analysis of immunoprecipitated TRPV4 (Figure 8A). Proplatelet 
forming Mks at 3 and 8 hours from the beginning of the experiment were 
quantified. The number of visible Mks per experiment was comparable in both 
conditions (CTRL 51±9 vs BAPN 58±13 at 3 hours; CTRL 63±14 vs BAPN 
72±17 at 6 hours), while the percentage of proplatelet forming Mks was 
significantly higher in LOX-inhibited mice (Figure 8B; Supplemental Video 1; 
Supplemental Video 2). Importantly, Akt inhibition in bone marrow explants, 
from BAPN treated mice, reverted the increase in proplatelet formation to a 
level lower than CTRL mice (Figure 8B; Supplemental Video 3). Finally, to 
further explore the direct dependence of PPF on collagen substrate 
crosslinking and thus rigidity, PPF in Mks plated on type IV collagen pre-
treated with recombinant LOXL2 protein was tested, in the presence or 
absence of BAPN. The incubation of type IV collagen with LOXL2 significantly 
reduced the percentage of proplatelet forming Mks, while inhibition of LOXL2 
with BAPN rescued PPF to a level comparable to type IV collagen alone 
(Supplemental Figure 7).  
 
Discussion 
The signaling pathways that control platelet formation in the bone marrow 
matrix environment have remained quite elusive. This study demonstrates 
that calcium influx through TRPV4 channels stimulates integrin β1 activation 
upon Mk adhesion on soft collagen substrate, promoting Akt phosphorylation 
and platelet formation. This previously unknown mechanism for platelet 
production adds new insights into the role of the ECM in regulating Mk 
function 44-46, and determines the importance of ECM-dependent calcium 
influx in regulating Mk spreading and PPF 17.   
 
The bone marrow microenvironment consists of various ECM components 
that interact with each other to form a structural framework that supports 
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tissue organization and positional cues regulating megakaryopoiesis. In this 
structure, type I and IV are the most abundant collagens. Notably, type IV can 
support PPF 29, while type I collagen is the only ECM component known to 
inhibit this process 9,10,12. This inhibition is triggered by the tensile strength of 
fibrils in type I collagen that regulates cytoskeleton contractility of Mks through 
activation of the Rho-ROCK pathway and MLC-2 phosphorylation 8,10. 
Consistently, culturing Mks in a soft methylcellulose (MC) hydrogels, 
determines an increase of PPF through activation of the myosin IIA and MKL1 
pathways 18. 
The current data showed that type I collagen displayed a significant higher 
stiffness than type IV collagen, as revealed by AFM analysis. Consistently, 
only Mks plated on the softer type IV collagen extended long and branched 
proplatelets. We hypothesized that specific collagen receptors may regulate 
the different Mk behavior on type I and type IV collagens. Among the collagen 
receptors, integrins have been extensively described to be major mechano-
receptors, due to their ability to modulate the signals transmitted inside the 
cell according to the physical properties of the ligand they bind 47. In support 
of this hypothesis, the adhesion of Mks on both collagens was found to be 
mostly mediated by β1 integrin. However, β1 integrin was significantly more 
active and more internalized in Mks plated on type IV than on type I collagen 
during an 8 hours incubation time. These data were in line with the notion that 
β1 integrin dynamics and internalization-recycling circle are regulated by 
matrix stiffness 48,49. Importantly, integrin detachment and internalization on 
soft substrate was previously shown in mesenchymal stromal cells, and was 
ascribed to the instability of the binding and, thus, to the low stress level 
necessary for the binding rupture 50. In contrast, when the substrate stiffness 
increases, the relative number of nascent and retracting β1 integrin adhesions 
are reduced, and highly stable adhesions are promoted 51. In accordance, by 
using passive silk films with different rigidities, substrate stiffness and β1 
integrin activation in Mks were shown to be inversely proportional, as softer 
substrates promoted β1 integrin activation and internalization. 
 
The increase in β1 integrin signaling that was observed on soft matrices, 
despite the higher rate of integrin internalization, is in line with recent work, 
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which demonstrated that endocytosis was necessary for full ECM-induced 
integrin mediated signaling 52. PI3K/Akt and MAPK/ERK signaling pathways 
are known to be activated downstream β1 integrin and responsible for PPF 
regulation 13-17. Interestingly, thrombocytopenia is one of the most frequent 
hematologic adverse events in patients treated with Perifosine, an oral Akt 
inhibitor used in cancer treatment 53. Consistently, in our experiments, Akt and 
not ERK phosphorylation promoted Mk maturation and PPF upon β1 integrin 
activation by soft substrates. These data prompted us to hypothesize that 
other mechano-sensitive molecules may be involved in the regulation of these 
signaling processes. The mechano-sensitive ion channels, a member of which 
is TRPV4, seemed to be the best candidates to explain the data. First, these 
ion channels detect and transduce external mechanical forces into electrical 
and/or chemical intracellular signals 22,54. Second, it was demonstrated that 
stretch-activated endothelial cells regulate Akt and ERK activation through a 
TRPV4-β1 integrin-dependent mechanism 24. Consistently, in the experiments 
Mks were shown to express functional TRPV4 ion channels that were 
selectively activated only upon Mk adhesion on soft substrates.  
Accordingly, TRPV4 channels present the unique ability to mediate an 
integrin-to-integrin signaling which is activated by mechanical forces 
transmitted by ECM components to β1 integrins. This results in the ultra-rapid 
(4 ms) alteration of the molecular conformation of TRPV4, which gates the 
channels and enables extracellular Ca2+ entry, thereby causing additional β1 
activation 24,25,55. 
Overall, these in vitro studies lead us to posit a model by which softer 
environment in the bone marrow promotes the activation of the TRPV4 ion 
channel that, in turns, leads to further β1 integrin stimulation and Akt 
phosphorylation, culminating with PPF. In line with this contention, adult mice 
treated with a specific LOX inhibitor that reduces tissue stiffness 42,43, 
promoted TRPV4, β1 integrin and Akt activation, with a consequent increase 
of platelet count in the peripheral blood.  This occurred while Mk numbers in 
the bone marrow were not affected. Of note, an unexplained trend in 
increased platelet count was also reported earlier upon LOX inhibitor 
administration 35, although the dosage of inhibitor used in that study was low, 
and tested in newborn to young mice. A recent study showed that upregulated 
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LOX, at a level similar to that found in pathological bone marrow fibrosis, led 
to increased platelet adhesion to monomeric collagen mediated via α2β1 
collagen receptors 56. A similar increase in adhesion was observed with 
regard to LOX over-expressing Mks. Together with our current studies, we 
propose that LOX is capable of augmenting Mk adhesion via collagen 
receptor activation, but whether these Mks effectively produce proplatelets or 
not also depends on LOX-regulated ECM stiffness and changes in TRPV4 
activation.  
 
During life, ECM components are continuously rearranged to permit cell-
tissue function. However, some patho-physiological conditions, such as aging 
or augmented bone marrow fibrosis determine an increase of ECM 
component rigidity, causing tissue function alterations 57,58. Interestingly, it is 
known that platelet count is inversely correlated with age and that in the late 
stages of primary myelofibrosis, when the bone marrow is filled of thick 
reticular fibers, thrombocytopenia occurs 59,60. Moreover, in these conditions, 
other organs, such as the lung 61 or the spleen 62, with a more favorable 
matrix environment, may become the site of platelet production. Based on 
these observations and on the mechanism described in the current work, we 
propose that beside the extensively described humoral-dependent 
mechanisms of platelet production, the physical properties of the ECM 
components that fill the bone marrow are crucial regulators of Mk function and 
platelet production.  
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Figure legends 
 
Figure 1. Type I and type IV collagens differently regulate 
megakaryocyte adhesion. A) Distribution of Young’s modulus values of live 
Mks plated on type I and type IV collagens. Three independent experiments 
were performed. B) Human mature Mks, 1 x 105 per well in 24 well plates, 
were plated on type I and type IV collagen coated coverslips for three different 
time. Cells were fixed and stained with anti-β1 tubulin (green) and 
tetramethylrhodamine (TRITC)-Phalloidin (red). Nuclei were counterstained 
with Hoechst (blue). Scale bar 50 μm; box scale bar 20 μm. C) Mks exhibiting 
stress fibers were counted and presented as percentage of spread Mk, while 
Mks extending proplatelets were counted and shown as percentage of 
proplatelet bearing Mks. Results shown in panels C are mean ± SD of six 
independent experiments; * p<0.05.  
 
Figure 2. β1 integrin is strongly involved in mediating megakaryocyte 
adhesion on type I and type IV collagens. A) Analysis of collagen 
receptors. qRT-PCR analysis of different collagen receptors in human mature 
Mks (left panel). Data are shown as mean ± SD, of four independent 
experiments, relative to the housekeeping gene β2-microglobulin. Mk 
adhesion on type I and IV collagens was evaluated upon treatment with 
different collagen receptor blocking antibodies or blocking molecules (10 
μg/mL anti-β1 integrin, 200 nM DDR1-IN-1, 10 μg/mL anti-GPVI) (right panel). 
Data are shown as mean percentage of adhering Mks ± SD, of five 
independent experiments, relative to untreated cells. B) Western blot analysis 
of active β1 integrin in Mks plated on type I and type IV collagens for different 
times. Total β1 integrin and actin were determined to show equal loading. The 
densitometry analysis of active β1 integrin level, derived from three 
independent experiments, is shown. C) β1 integrin internalization assays. 
Western blot analysis of internalized β1 integrin after 1, 3 and 8 hours of 
adhesion on type I and type IV collagens (upper panel). To show equal 
loading actin was determined on total cell lysates. The first lane on the left 
represents the positive control of untreated Mks. The densitometry analysis of 
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internalized β1 integrin level, derived from four independent experiments, is 
shown. Immunofluorescence analysis of internalized β1 integrin in Mks plated 
on type I and type IV collagens for 3 hours (bottom panel). Mks were stained 
with anti-β1 integrin (green) and TRITC-Phalloidin (red). Nuclei were 
counterstained with Hoechst (blue). Scale bar 10 μm. The densitometry 
analysis of staining intensities, derived from four independent experiments, is 
shown. A minimum of 20 cells per experiment was evaluated. Data of 
densitometry analysis are all expressed as mean ± SD; * p<0.05. 
 
Figure 3. Collagen substrate elasticity regulates β1 integrin dynamics 
and proplatelet formation. A) Mks extending proplatelets were counted and 
shown as percentage of proplatelet bearing Mks. Data are expressed as 
mean percentage ± SD of eight independent experiments. B) Western blot 
analysis of active β1 integrin in Mks plated on type I and type IV collagen 
coated soft and stiff silk fibroin films. Total β1 integrin and actin were 
determined to show equal protein loading. The densitometry analysis of active 
β1 integrin level, derived form four independent experiments is shown. C) β1 
integrin internalization assays. Western blot analysis of internalized β1 
integrin after 1, 3 and 8 hours of adhesion on type I collagen-coated soft and 
stiff silk fibroin films (left panel). Actin, in total cell lysates, was determined to 
show equal loading. The first lane on the left represents the positive control of 
untreated Mks. The densitometry analysis of internalized β1 integrin level, 
derived form four independent experiments, is shown. Immunofluorescence 
analysis of internalized β1 integrin in Mks plated on type I collagen-coated 
soft and stiff silk fibroin films for 3 hours (right panel). Cells were stained with 
anti-β1 integrin (green) and TRITC-Phalloidin (red). Nuclei were 
counterstained with Hoechst (blue). Scale bar 10 μm. The densitometry 
analysis of staining intensities, derived form four independent experiments, is 
shown. A minimum of 20 cells per experiment was evaluated. Data of 
densitometry analysis are all expressed as mean ± SD; * p<0.05 **p<0.01. 
 
Figure 4. PI3K/Akt signaling mediates proplatelet formation on soft 
collagen substrates. A) Western blot analysis of Akt and ERK 
phosphorylation (pAkt and pERK) in Mks plated for 3, 8 and 16 hours on type 
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I and type IV collagens (left panel). Total Akt, ERK and actin were determined 
to show the equal loading. The densitometry analysis of pAkt and pERK level, 
derived from four independent experiments, is shown. Proplatelet formation 
assay in Mks plated for 16 hours on type IV collagen in presence or not of 10 
μM Akt inhibitor (right panel). Mks extending proplatelet were counted and 
shown as percentage of proplatelet bearing Mks. Data are expressed as 
mean percentage ± SD of five independent experiments. B) Western blot 
analysis of pAkt and pERK in Mks plated for 3 hours on type I and type IV 
collagen coated soft and stiff silk fibroin films (left panel). Total Akt, ERK and 
actin were determined to show equal loading. The densitometry analysis of 
pAkt and pERK level, derived from five independent experiments, is shown. 
Proplatelet formation assay in Mks plated for 16 hours on type I collagen 
coated soft silk fibroin films in presence or not of 10 μM Akt inhibitor (right 
panel). Mks extending proplatelets were counted and expressed as 
percentage of proplatelet bearing MKs. Data are expressed as mean 
percentage ± SD of five independent experiments. Data of densitometry 
analysis are all expressed as mean ± SD; * p<0.05. 
 
Figure 5. Megakaryocytes express a functional TRPV4 ion channel. A) 
TRPV4 expression in mature Mks. RT-PCR analysis of TRPV4 (left panel). 
Western blot analysis of TRPV4 (right panel). B) Functional characterization 
of TRPV4. Analysis of calcium signaling in response to 10 nM GSK1016790A 
(TRPV4 agonist) in FURA2–AM loaded Mks pretreated or not, for 60 minutes, 
with 10 μM of the indicated TRPV4 inhibitor (RN-1734 or HC067047) (left 
panel). GSK1016790A was added at 100 seconds from the beginning of the 
analysis. Data are representative of three independent experiments. A 
minimum of 40 Mks per experiment was evaluated. In absence of extracellular 
calcium (0Ca2+) treatment with 10 nM GSK1016790A did not elicited 
significant changes in calcium signaling in FURA2–AM loaded Mks (right 
panel). After extracellular calcium restoration, in presence of GSK1016790A, 
the increase in Mks fluorescence was indicative of extracellular calcium entry 
in Mks cytosol. GSK1016790A was added after 300 seconds from the 
beginning of the experiment. Data are representative of three independent 
experiments. A minimum of 40 Mks per experiment was evaluated. C) TRPV4 
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activity on type I and IV collagens. Number of calcium peaks per Mks plated 
on type I and type IV collagens in presence or not of 10 μM RN-1734. Time of 
analysis was 800 seconds. Calcium peak amplitude in megakaryocytes plated 
on type I and type IV collagens in presence or not of 10 μM RN-1734 (left 
panel). Representative calcium oscillations in Mks plated on type I and type IV 
collagens (right panel). RN-1734 was added at 600 seconds from the 
beginning of the analysis. Data in panels C refers to eight independent 
experiments. Data are expressed as mean ± SD; * p< 0.05 ** p<0.01. 
 
Figure 6. TRPV4 activity regulates β1 integrin dynamics and Akt 
phosphorylation. A) Western blot analysis of active β1 integrin and 
phosphorylated Akt (pAkt) in Mks plated on type IV collagen in presence or 
not of 10 μM RN-1734 (RN). Total β1 integrin, Akt and actin were determined 
to show equal loading. The densitometry analysis of active β1 integrin level 
and pAkt, derived form four independent experiments is shown. B) Proplatelet 
formation assay in Mks plated on type IV collagen in presence or not of 10 μM 
RN-1734. Proplatelet bearing Mks were counted and shown as percentages 
of proplatelet bearing Mks. Data are shown as mean percentage ± SD of six 
independent experiments. C) Western blot analysis of active β1 integrin and 
pAkt in Mks plated on type I collagen in presence or not of 10 nM 
GSK1016790A (GSK). Total β1 integrin, Akt and actin were determined to 
show equal loading. The densitometry analysis of active β1 integrin level and 
pAkt, derived form four independent experiments, is shown. β1 integrin 
internalization assays. D) Immunofluorescence analysis of internalized β1 
integrin in Mks plated on type I collagen in presence or not of 10 nM 
GSK1016790A (left panel). Cells were stained with anti-β1 integrin (green) 
and TRITC-Phalloidin (red). Nuclei were counterstained with Hoechst (blue). 
Scale bar 5 μm. The densitometry analysis of staining intensities, derived 
form three independent experiments, is shown. A minimum of 20 cells per 
experiments was evaluated. Western blot analysis of internalized β1 integrin 
in megakaryocytes plated on type I collagen in presence or not of 10 nM 
GSK1016790A (right panel). To show equal loading actin was determined on 
total cell lysates. The densitometry analysis of internalized β1 integrin level, 
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derived form three independent experiments is shown. Data of densitometry 
analysis are all expressed as mean ± SD; * p<0.05.  
 
Figure 7. Lysyl oxidase-mediated collagen crosslinking inhibition 
increases platelet production in vivo. A) Elastic modulus of untreated 
(CTRL) and BAPN-treated mice bone marrows. Data refers to four different 
mice per group. Bone marrow from both femurs per mouse was analyzed. B) 
Peripheral blood platelet count of untreated (CTRL) and BAPN-treated mice. 
Data refers to ten mice per group. Reticulated platelet measurements in 
peripheral blood of untreated (CTRL) and BAPN-treated mice. Data refers to 
eight mice per group. C) pAkt analysis in CTRL and BAPN treated mouse Mks 
was performed by BM section immunofluorescence (left panel) and by flow 
cytometry (right panel). The densitometry analysis of pAkt 
immunofluorescence staining, of bone marrow Mks, is derived from four mice 
per group. At least 30 Mks per section were analyzed. The flow cytometry 
analysis of pAkt phosphorylation was performed in CD41+ bone marrow Mks. 
The mean fluorescence intensity (MFI) is shown. Data are expressed as 
mean ± SD of five independent experiments. Data of densitometry analysis 
are all expressed as mean ± SD; * p<0.05.  
 
Figure 8. Lysyl oxidase-mediated collagen crosslinking inhibition 
increases proplatelet formation and TRPV4 activation ex vivo. A) 
Western blot analysis of TRPV4 immunoprecipitated from bone marrow 
immunomagnetically-sorted Mks. A control sample was immunoprecipitated 
with an unrelated antibody (IgG). Membranes were probed with anti-PKC-
substrates antibody (recognizing phosphorylated serine) and with anti-TRPV4 
antibody. Actin staining on total cell lysates is shown to ensure equal loading. 
The densitometry analysis of the phosphorylated TRPV4/total TRPV4 ratio is 
shown. Data refers to three independent experiments. B) Proplatelet 
formation assay in BM explants. Mks extending proplatelet were counted after 
3 and 8 hours from the beginning of the experiment, and shown is the 
percentage of proplatelet bearing Mks. Data are expressed as mean 
percentage ± SD. n = 10 CTRL, 10 BAPN, 3 BAPN + AKT inhibitor (AKT INH). 
C) Representative pictures of proplatelet bearing Mks in bone marrow 
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explants. Mks were stained as living cells with anti-CD41-FITC antibody. Data 
of densitometry analysis are expressed as mean ± SD; Scale bar = 50 μm 
upper pictures; 100 μm lower pictures. * p<0.05.  
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SUPPLEMENTAL MATERIALS AND METHODS 
 
Antibodies  
The following antibodies were used: anti- β1 tubulin (kind gift of Prof. J. 
Italiano Jr); clone HUTS-4, anti-active β1 integrin (Millipore); anti- β1 integrin 
(Abcam); anti-βActin (Sigma Aldrich); anti-pAKT (ser473; Cell Signaling); anti-
Akt (Cell Signaling); anti-pERK (Thr185/Tyr187; Millipore); anti-ERK (Cell 
Signaling); anti-TRPV4 (Abcam); anti-PE-pAKT (BD Pharmingen); anti-PKC 
substrates (pSer/pThr; Cell Signaling). 
 
Evaluation of megakaryocyte spreading and proplatelet formation 
To analyze Mk spreading and proplatelet formation (PPF) onto collagens, 12 
mm glass coverslips or silk films were coated with 25 µg/mL type I (gift of 
Prof. Maria Enrica Tira; University of Pavia) or type IV collagen (acid soluble) 
(Sigma Aldrich) overnight at 4°C. At day 13 of differentiation, mature Mks 
were harvested and allowed to adhere at 37°C and 5% CO2. To evaluate both 
the number of spread Mks and PPF, samples were fixed and stained at three 
well-defined time points, namely at 3, 8 and 16 hours post cell layering on 
coated surface 1. These points have been previously shown to be 
representative of active adhesion (3 hours), starting of PPF (8 hours), and the 
zenith of PPF and platelet release (16 hours) 2. The number of spread Mks 
was assessed as follows: β1 tubulin positive Mks exhibiting stress fibers 
(stained with TRITC-Phalloidin) were counted and expressed as percentage 
of spread Mks. PPF were counted as percentage of total Mks.  
 
Immunoprecipitation and Western blotting 
Cultured Mks and primary BM immunomagnetically-sorted Mks (CD41+; 
Biolegend) were collected, washed twice at 4°C and lysed in hepes-glycerol 
lysis buffer (Hepes 50 mM, 10% glycerol, 1% Triton x-100, MgCl2 1.5 mM, 
EGTA 1mM) containing aprotinin 1 µg/mL and leupeptin 1 µg/mL, for 30 min 
at 4°C, as previously described 3. After centrifugation at 15700xg for 15’ at 
4°C, Laemmli sample buffer was added to supernatants. For active β1 integrin 
staining (clone HUTS-4) samples were not reduced. Samples were then 
heated at 95 °C for 3’ and loaded and run on 8% or 12% sodium dodecyl 
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sulfate polyacrylamide gel (SDS-PAGE) and transferred to polyvinylidine 
fluoride membranes (PVDF). Membranes were incubated with 5% BSA, 0.1% 
Tween in PBS to avoid non specific antibody binding, and then probed with 
primary antibodies and the appropriate peroxidase conjugated secondary 
antibodies. Western blots were developed with enhanced chemiluminescence 
reagents and Chemidoc XRS Imaging System (BioRad). For 
immunoprecipitation, cellular lysates were precleared by incubation with 
protein A-Sepharose. Precleared lysates were incubated with 2 µg of anti-
TRPV4 antibody (4 µg/mL; Abcam) for 4 h at 4°C on a rotatory shaker, 
followed by adding 100 µL of 50 mg/ml protein A-Sepharose and incubation 
overnight at 4°C on a rotatory shaker. Beads were washed three times in lysis 
buffer.  
 
Immunofluorescence microscopy 
The cover-slips were mounted onto glass slides with ProLong Gold antifade 
reagent (Invitrogen). For immunofluorescence staining of BM samples, 
sections were fixed for 20 minutes in 4% PFA, washed with PBS, and blocked 
with 2% bovine serum albumin (BSA) (Sigma-Aldrich) in PBS for 30 minutes. 
Non-specific binding sites were saturated with a solution of 5% goat serum, 
2% BSA, and 0.1% glycine in PBS for 1 hour. Specimens were incubated with 
primary antibodies in washing buffer (0.2% BSA, 0.1% Tween in PBS) 
overnight at 4°C. After three washes, sections were incubated with 
appropriate fluorescently conjugated secondary antibodies in washing buffer 
for 1 hour at room temperature (RT). Nuclei were counterstained using 
Hoechst 33258 (100 ng/mL in PBS) at RT for 3 minutes. Sections were then 
mounted with micro-cover glass slips using Fluoro-mount (Bio-Optica). 
Negative controls were routinely included by omitting the primary antibodies.  
 
Internalization assays 
For immunofluorescence internalization assay, Mks were washed in RPMI 
medium (Euroclone) containing 0.1% BSA and pre-cooled on ice before 
treatment with 15 µg/ml of anti-β1 integrin antibody (Abcam) (1x105 cells in 
100 µl RPMI, 0.1% BSA with mAb) for 30 minutes on ice with gentle agitation. 
After washing with ice-cold RPMI, 0.1% BSA to remove unbound antibody, 
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cells were seeded on type I or type IV collagen-coated coverslips, or on type I 
collagen coated soft and stiff silk films for 3 hour at 37°C. Before fixation, cells 
were placed on ice and acid washed (three washes with ice-cold 50 mM 
glycine in Ca2+/Mg2+ HBSS, pH 2.5, and two washes with Ca2+/Mg2+ 
HBSS, pH 7.5) to remove the antibody from the cell surface. Mks were then 
fixed, permeabilized, and stained with the appropriate secondary antibody as 
described in the “immunofluorescence microscopy” section 4.  
For western blotting internalization assay, Mks at day 13 of culture (1.5x106) 
were cooled on ice and washed in pre-chilled PBS before incubation with PBS 
0.5 mg/mL thiol-cleavable Sulfo-NHS-S-S-Biotin (Pierce Chemical Co.) for 1 
hour on ice. After washing with ice-cold PBS, labeled Mks were resuspended 
in serum-free RPMI medium and plated on the indicated substrates for the 
indicated time points at 37°C to allow β1 integrin internalization. After plating 
Mks for indicated times, samples were returned to ice, washed three times 
with ice-cold PBS, and treated with two successive reductions of 20 minutes 
with a reducing solution containing the non-membrane permeable reducing 
agent glutathione (GSH; 42 mM), 75 mM NaCl, 1 mM EDTA, 1% bovine 
serum albumin and 75 mM NaOH. To evaluate total labeling, a sample was 
not reduced with GSH.  
 
Silk solution preparation 
Silk fibroin aqueous solution was obtained from Bombyx mori silkworm 
cocoons according to previously published literature 5-7. Briefly, Bombyx mori 
cocoons were de-wormed and chopped. 5 g of chopped cocoons were boiled 
for 10 minutes in 2 L of 0.02 M Na2CO3 solution. Resulting fibers were rinsed 
for three times in distilled water and dried overnight. The dried fibers were 
solubilized for 4 hours at 60°C in 9.3 M LiBr at a weight to volume ratio of 3 
g/12 mL. The solubilized silk solution was dialyzed against distilled water 
using a Slide-A-Lyzer cassette (Thermo Scientific) with a 3,500 MW cutoff for 
three days. Water was changed a total of eight times. The silk solution was 
centrifuged at 3220xg for 10 minutes to remove large particulates and stored 
at 4°C. 
 
Silk film fabrication and assembly of the transwell chamber system 
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Silk solution (1% w/v), was cast on 6 well plates (45 µL/cm2 of surface area) 
and dried at 22°C for 16 hours. Silk films were water annealed in a vacuum 
chamber, containing 100 mL of water at the bottom of chamber, for stiffness 
tuning. The water annealing chamber was maintained at either 60°C for 16 
hours or 4°C for 6 hours to achieve stiff or soft silk film mechanical properties, 
respectively. Before Mk plating, silk films were exposed to ultraviolet light for 
30 minutes per side inside of a sterile biological hood. For 
immunofluorescence experiments, films were cast on polydimethylsiloxane 
(PDMS) mold and dried at 22°C for 16 hours. Silk films were lift off the PDMS 
mold and water annealed as described in the text. Successively, silk films 
were secured between two rings of scotch tape (6 mm inner diameter, 12 mm 
outer diameter) and secured to the bottom of a 24-well plates using silicon 
rings (10 mm inner diameter, 15.5 mm outer diameter, McMaster Carr). All 
samples were sterilely washed three times in PBS over the course of 24 
hours. The transwell chamber system for the analysis of platelet production 
was assembled as previously described 8. Briefly, silk solution (1% w/v) was 
mixed with polyethylene oxide (PEO) porogen (0.05% w/v; Sigma) before 
casting on the PDMS mold, dried and water annealed in order to obtain 
porous silk films of different stiffness. The membrane from transwell inserts 
(Corning) was then removed under sterile conditions using a biopsy punch. 
Porous silk films were trimmed using an 8 mm diameter biopsy punch and 
secured to the transwell insert using a sterile, medical-grade silicon glue (Dow 
Corning). The films were rinsed three times in PBS over the course of 24 
hours to remove the PEO porogen. In all experiments, silk films were soaked 
in cell culture media for one hour, prior to cell seeding. 
 
Elastic modulus determination via Atomic Force Microscope 
Elastic modulus maps were taken on an Asylum Research MFP-3D Atomic 
Force Microscope (AFM) (Asylum Research) using AC240TS-R3 cantilevers 
(Asylum Research) with a nominal spring constant of 2 N/m. Films were 
hydrated with PBS and a minimum of 300 AFM force vs. indentation curves 
were taken in the fluid solution on each film. Cantilevers were calibrated in air 
and in the buffer solution prior to measurement to determine accurate spring 
constant values. Elastic modulus values were determined using the inbuilt 
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Hertz Model fitting function of the Asylum Research MFP3D software 9. To 
analyze collagen structures in different conditions, type I and type IV were 
coated on silk films cast on glass coverslips as described in “Silk film 
fabrication” and then observed by tapping-mode atomic force microscopy on a 
Digital Instruments multimode Nano- Scope III/a SPM (Digital Instruments) 
with Olympus OTR 8 oxide-sharpened silicon nitride probes 3. 
 
Reverse transcription (RT)-PCR and quantitative Real Time PCR 
In vitro differentiated Mks at day 13 of culture were purified using 
immunomagnetic beads technique 9. Total RNA was extracted using the 
Mammalian GeneElute total RNA kit (Sigma-Aldrich). Retrotrascription (RT) 
was performed using the iScriptTM cDNA Synthesis Kit according to the 
manufacturer instructions (BioRad). RT-PCR was performed as previously 
described 3. For quantitative Real Time PCR, RT samples were diluted up to 
three times with ddH2O and the resulting cDNA was amplified in triplicate with 
200 nM of primers and SsoFast Evagreen Supermix (BioRad). The 
amplification was performed in a CFX Real-time system (BioRad) as follows 
95°C for 5’, 35 cycles at 95°C for 10’’, 60°C for 15’’, 72°C for 20’’. Pre-
designed KiCqStart primers were purchased from Sigma Aldrich (Milan, Italy). 
The BioRad CFX Manager software 3.0 was used for the normalization of the 
samples (BioRad). β -2 microglobulin gene expression was used for 
comparative quantitative analysis. 
 
Elastic modulus determination via Atomic Force Microscope 
Elastic modulus maps were taken on an Asylum Research MFP-3D Atomic 
Force Microscope (AFM) (Asylum Research) using AC240TS-R3 cantilevers 
(Asylum Research) with a nominal spring constant of 2 N/m. Films were 
hydrated with PBS and a minimum of 300 AFM force vs. indentation curves 
were taken in the fluid solution on each film. Cantilevers were calibrated in air 
and in the buffer solution prior to measurement to determine accurate spring 
constant values. Elastic modulus values were determined using the inbuilt 
Hertz Model fitting function of the Asylum Research MFP3D software 9.  
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[Ca2+]i measurements 
PSS consists of: NaCl 150 mM, KCl 6 mM, CaCl2 1.5 mM, MgCl2 1 mM, 
glucose 10 mM, Hepes 10 mM. In Ca2+-free solution (0Ca2+), Ca2+ was 
substituted with NaCl 2 mM and EGTA 0.5 mM was added. Solutions were 
titrated to pH 7.4 with NaOH. After washing in PSS, the coverslip was fixed to 
the bottom of a Petri dish and the cells were observed using an upright 
epifluorescence Axiolab microscope (Carl Zeiss), usually equipped with a 
Zeiss X63 Achroplan objective (water-immersion, 2.0mm working distance, 
0.9 numerical aperture). Mks were excited alternately at 340 and 380 nm, and 
the emitted light was detected at 510 nm. See Supplemental methods. A first 
neutral density filter (1 or 0.3 optical density) reduced the overall intensity of 
the excitation light and a second neutral density filter (0.3 optical density) was 
coupled to the 380 nm filter to approach the intensity of the 340 nm light. A 
round diaphragm was used to increase the contrast. The excitation filters 
were mounted on a filter wheel (Lambda 10; Sutter Instrument). Custom 
software, working in the LINUX environment, was used to drive the camera 
(Extended-ISIS Camera; Photonic Science) and the filter wheel and to 
measure and plot on-line the fluorescence from 10 to 15 rectangular regions 
of interest (ROI) enclosing 10-15 single cells. [Ca2+]i was monitored by 
measuring, for each ROI, the ratio of the mean fluorescence emitted at 510 
nm when exciting alternatively at 340 and 380nm (shortly termed ‘‘ratio’’). An 
increase in [Ca2+]i causes an increase in the ratio 2.  
 
Animals and in vivo treatment 
For in vivo BAPN treatment, mice were injected with 350 mg/Kg/day of BAPN 
(Sigma Aldrich) and were given drinking water containing 0.2% (w/v) BAPN 
for 14 days. At day 14 after the first injection, mice were sacrificed and blood 
was collected for peripheral blood count. Femurs were fixed in 3% PFA or 
alternatively flushed and used for flow cytometry analysis, BM explants and 
Mk cell sorting experiments. Age- and sex-paired mice (10-12 weeks-old 
males) were injected with PBS as control. Cell count and differential cell count 
in blood samples were performed on an ADVIA 120 hematology analyzer 
(Siemens).  
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In vivo bone marrow stiffness  
Samples were subjected to cyclic uniaxial compression test with a strain rate 
of 0.01 s-1, up to 4% deformation, at room temperature and in wet condition. 
Before testing, samples were preserved in PBS, and their length and cross 
sectional area were measured with a caliper (10 µm resolution). The 
compressive elastic modulus of each sample was evaluated from the slope of 
the first linear portion of the stress–strain curve 10. 
 
Flow cytometry  
All samples were acquired with a Beckman Coulter FacsDiva flow cytometer 
(Beckman Coulter Inc.). The analytical gating were set using unstained 
samples and relative isotype controls. Off line data were analyzed using 
Beckman Coulter Kaluza version software package (Beckman Coulter Inc.).  
 
Bone marrow explants 
Intact bone marrows were obtained by flushing mouse femurs with PBS 
buffer. Ten 0.5 mm thick transversal sections from one femur from the same 
mouse were placed at 37°C in an incubation chamber containing DMEM 
medium supplemented with 5% mouse serum. Living tissue sections were 
examined by phase contrast under an inverted microscope (Olympus IX53). 
Images for video were acquired sequentially at 8-minutes intervals with 
Olympus FluoView FV10i and processed with FV10 ASW 4.0 software 
(Olympus). Mks were stained as living cells with anti-CD41-FITC antibody 
(0.001mg/mL; Biolegend) making them visible and recognizable within the 
explants. Mks were classified as proplatelet forming cells when at least one 
thin extension presenting a proplatelet bud was observed. To perform TRPV4 
immunoprecipitation in Mks from BM explants, Mks were sorted by 
immunostaining with a phycoerythrin (PE)-conjugated anti-mouse CD41 (0.1 
mg/mL; Biolegend) followed by incubation with anti-PE immunomagnetic 
beads (Miltenyi biotech). The purity of isolated Mks, by means of CD42b and 
CD61 staining, were routinely analyzed.  
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Tissue collection and immunohistochemistry 
Femurs from treated and control animals were removed and fixed for 24 hours 
in 3% paraformaldehyde (PFA). Bones were decalcified in a solution of 10% 
EDTA in PBS (w/o calcium and magnesium) pH 7.2, for 2 weeks at 4°C. 
Bones were embedded in OCT cryosectioning medium and snap frozen in a 
chilling bath. 8 µm tissue sections were taken using a Microm Microtome HM 
250 (Bio Optica S.P.A.) and stained with anti-CD41 (0.1 mg/mL in 
PBS/1%BSA/0.3% Triton X-100; Biolegend) and anti-pAkt (diluted 1:25 in 
PBS/1%BSA/0.3% Triton X-100; Cell signaling) and the appropriate 
secondary antibodies for fluorescence microscopy analysis 7.  
 
Reticulated platelet analysis 
To assess platelet production in vivo, a small sample of blood was collected 
from the tail vein and placed in anticoagulant. The blood was then diluted 20x 
in 2 mM EDTA in PBS before the addition of 100 ng/mL thiazole orange 
(Sigma Aldrich) for 60 minutes at room temperature to label reticulated 
platelets. The samples were then fixed in 1% PFA for 15 minutes and 
analyzed by flow cytometry. Thiazole orange-positive/CD41+ platelets were 
considered reticulated 11. 
 
Lox-mediated collagen crosslinking 
Recombinant LOXL2 was purchased by R&D systems (2369-AO). Acid 
soluble type IV collagen (25 µg/mL; Sigma Aldich) was coated on 96-well 
plates alone or in combination with 4µg/mL of LOXL2 recombinant protein, or 
in combination with 4µg/mL of LOXL2 recombinant protein plus 200 µM 
BAPN, overnight at 4°C, following by incubation at 37°C for 24 hours and by 
three washes with PBS, prior to cell plating 12,13. After 16 hours, non-adherent 
cells were removed and adhering Mks were fixed with 4% PFA. Proplatelet 
forming Mks were counted and expressed as percentage of proplatelet 
bearing Mks, using protocols we previously employed 1. 
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Statistics 
Values are expressed as mean ± SD. t test was used to analyze experiments. 
A value of p<0.05 was considered statistically significant. All experiments 
were independently repeated at least three times. 
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SUPPLEMENTAL FIGURES AND FIGURE LEGENDS 
 
 
 
 
SUPPLEMENTAL FIGURE 1. A) Representative images of active beta 1 
integrin immunofluorescence staining in human mature Mks plated, for 3 
hours, on type I collagen or type IV collagen coated soft or stiff silk fibroin 
films. Staining intensities were quantified by ImageJ software. n = 100 Mks 
per experimental condition in at least three independent experiments. Staining 
intensities are expressed relative to soft. * p < 0.05   
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SUPPLEMENTAL FIGURE 2. A) Schematic representation of the transwell 
system for platelet (Plts) production. B) Representative flow cytometry dot plot 
of platelets collected in the lower chamber of the system. Platelets were 
stained with anti-CD41 and anti-CD42b antibodies and counted with bead 
standard. C) Number of CD41+/CD42b+ platelets in the different experimental 
conditions. n = 3 per experimental condition.  
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SUPPLEMENTAL FIGURE 3. A) Western blot analysis of phosphorylated 
TRPV4 in Mks plated for 3 hours on type I and type IV collagen. Mk were 
lysed and TRPV4 immunoprecipitated with anti TRPV4 antibody. Membranes 
were probed with anti-PKC substrates antibody and re-probed with anti-
TRPV4 antibody to show the equal loading. B) Western blot analysis of 
phosphorylated TRPV4 in Mks plated for 3 hours on type I collagen coated 
SOFT or STIFF silk films. Mk were lysed and TRPV4 immunoprecipitated with 
anti TRPV4 antibody. Membranes were probed with anti-PKC substrates 
antibody and re-probed with anti-TRPV4 antibody to show the equal loading. 
A control sample was immunoprecipitated with an unrelated antibody (IgG). 
C) Densitometry analysis of the western blot in A and B. Data are expressed 
as mean ± SD for three independent experiments per each class of 
experiments. * p<0.05. 
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SUPPLEMENTAL FIGURE 4. A) Photomicrographs of CTRL and BAPN 
treated mouse femurs stained with picrosirius red, viewed under an 
orthogonal polarizing filters. Scale bar 100 µm.  
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SUPPLEMENTAL FIGURE 5. A) Photomicrographs of CTRL and BAPN 
treated mouse femurs stained with Hematoxylin and Eosin. Bone marrow Mks 
are clearly visible (arrows). B) Bone marrow Mks were counted and 
expressed as number of Mks per mm2. Data are expressed as mean ± SD  
(n=4). 
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SUPPLEMENTAL FIGURE 6. A) Flow chart of the bone marrow explant 
experiments. B) Phase contrast photomicrographs of CTRL and BAPN treated 
bone marrow explants after 3 and 8 hours from the beginning of the 
experiments. Proplatelet extending Mks are visible (arrows). Scale bar 50 µm 
(box scale bar 10 µm). BM (bone marrow).  
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SUPPLEMENTAL FIGURE 7. Mature Mks were plated for 16 hours on 96-
well plates coated with 25 µg/mL type IV collagen alone, type IV collagen pre-
treated overnight with 4µg/mL LOXL2, or type IV collagen pre-treated with 
4µg/mL LOXL2 + 200 µM BAPN overnight, as detailed under Methods. After 
16 hours of adherence cells were fixed and counted for proplatelet formation. 
Data are expressed as mean ± SD  (n=5) * p<0.05.  
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SUPPLEMENTAL TABLE 1.  
Blood cell count in CTRL and BAPN treated mice. Data refer to ten mice per 
group.  
 
Supplemental Video 1. Videoclip of Mks extending proplatelets in bone 
marrow explants from CTRL mice. After bone marrow explant, Mks were 
stained as living cells with anti-CD41-FITC antibody. Images were acquired 
sequentially (1 frame/8 minutes) and the movie was accelerated to 1 
frame/400 milliseconds. Total real duration: 160 min. An average of one Mk 
extending proplatelets per field is visible.  
Supplemental Video 2. Videoclip of Mks extending proplatelets in bone 
marrow explants from BAPN treated mice. After bone marrow explant, Mks 
were stained as living cells with anti-CD41-FITC antibody. Images were 
acquired sequentially (1 frame/8 minutes) and the movie was accelerated to 1 
frame/400 milliseconds. Total real duration: 160 min. An average of three Mks 
extending proplatelets per field is visible. 
Supplemental Video 3. Videoclip of Mks extending proplatelets in bone 
marrow explants from BAPN treated mice treated with an Akt inhibitor. After 
bone marrow explant, Mks were stained as living cells with anti-CD41-FITC 
antibody. Images were acquired sequentially (1 frame/8 minutes) and the 
movie was accelerated to 1 frame/400 milliseconds. Total real duration: 160 
min. Mks present a significantly decreased ability to extend proplatelets. 
 
 	
